We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDirecta Plus Regulatory News (DCTA)

Share Price Information for Directa Plus (DCTA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.70
Bid: 18.40
Ask: 19.00
Change: 0.00 (0.00%)
Spread: 0.60 (3.261%)
Open: 18.70
High: 18.70
Low: 18.70
Prev. Close: 18.70
DCTA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

18 Jun 2019 13:36

RNS Number : 6492C
Directa Plus PLC
18 June 2019
 

18 June 2019

 

Directa Plus plc

("Directa Plus" or the "Company")

 

Results of Annual General Meeting

 

The Company is pleased to announce that at its Annual General Meeting held earlier today (the "Meeting") all the resolutions set out in the Notice of the Meeting, save for resolution 7, were passed by the requisite majority.

 

Each of the resolutions put to the Meeting were voted on by way of a poll. The results of the poll for each resolution were as follows:

 

Resolution 

(* indicates special resolution)

Votes

For

%

Votes

Against

%

Shares Marked As Votes Withheld / Abstentions

Resolution 1 - To receive the Company's annual report and accounts for the period ended 31 December 2018

 

28,018,391

100.00

0

0

0

Resolution 2 - To re-elect Sir Peter Middleton as a Director

 

28,018,391

100.00

0

0

0

Resolution 3 - To re-elect Marco Ferrari as a Director

 

28,018,391

100.00

0

0

0

Resolution 4 - To re-appoint BDO LLP as Auditors of the Company

 

28,013,120

99.98

5,271

0.02

0

Resolution 5 - To authorise the Audit Committee to fix the remuneration of the Auditors

 

28,017,456

100.00

935

0.00

0

Resolution 6 - To authorise the Directors to allot Ordinary Shares under section 551 of the Companies Act 2006

 

23,975,456

85.57

4,042,935

14.43

0

Resolution 7* - To authorise the Directors to disapply pre-emption rights

 

12,133,682

44.56

15,095,395

55.44

789,314

Resolution 8* - To authorise the Directors to purchase the Company's own shares

 

23,102,348

84.84

4,126,729

15.16

789,314

 

The Board acknowledges the majority vote against resolution 7 in relation to authorising the Directors to allot Ordinary Shares on a non pre-emptive basis.

 

In the lead up to the AGM, we engaged with shareholders on this issue and have reviewed the feedback. We appreciate the time given and comments offered which have provided us with a clearer understanding of shareholder views.

 

As part of our approach to stakeholder engagement, we believe that it is in the best interests of the Company to listen and continue to engage with shareholders, to help formulate our approach to such engagement going forward, and explain why the Board considers the resolution to be in the best interests of the Company and our shareholders.

 

NOTES:

1.

Proxy appointments which gave discretion to the Chairman of the Meeting have been included in the "For" total for the appropriate resolution.

2.

Votes "For" and "Against" any resolution are expressed as a percentage (rounded to two decimal places) of votes validly cast for that resolution.

3.

A "Vote withheld" is not a vote in law and is not counted in the calculation of the percentage of shares voted "For" or "Against" any resolution.

4.

The full text of the resolutions passed at the Meeting can be found in the Notice of Meeting which is available on the Company's website at: http://www.directa-plus.com/

5.

These poll results will be available shortly on the Company's website at: http://www.directa-plus.com/

 

For further information please visit http://www.directa-plus.com/ or contact:

 

Directa Plus plc

+39 02 36714458

Giulio Cesareo, CEO

 

Marco Ferrari, CFO

 

 

 

Cantor Fitzgerald Europe (Nominated Adviser and Joint Broker)

+44 20 7894 7000

Rick Thompson, Philip Davies Will Goode(Corporate Finance)

 

Caspar Shand Kydd (Sales)

 

 

 

N+1 Singer (Joint Broker)

+44 20 7496 3069

Mark Taylor, Lauren Kettle

 

 

 

Tavistock (Financial PR and IR)

+44 20 7920 3150

Simon Hudson, Barney Hayward, Edward Lee

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGEAAKPFDDNEFF
Date   Source Headline
15th Apr 20243:01 pmRNSNotification of major holdings
12th Apr 20247:00 amRNSGiPave® installed at Imola Circuit
25th Mar 20247:00 amRNSEUR 1,000,000 Loan Agreement Signed
22nd Mar 20247:00 amRNSCollaboration with UK-based Heathcoat Fabrics
26th Feb 20247:00 amRNSAcquisition of 49% minority interest in Setcar
31st Jan 20247:00 amRNSContract win with FORD Otosan
20th Dec 20237:00 amRNSAcquisition of groundbreaking technology
15th Dec 202311:44 amRNSExpansion of collaboration with Miguel Caballero
10th Nov 20237:00 amRNSChange of Nominated Adviser
27th Sep 20237:00 amRNSHalf-year Report
18th Sep 20237:00 amRNSStrategic collaboration with The SPECTRUM Group
8th Sep 20237:00 amRNSNotice of Interim Results
7th Sep 20237:00 amRNSSignificant contract secured with LIBERTY Galati
19th Jul 20237:00 amRNSProject tender awarded
29th Jun 20237:00 amRNSDirecta Plus receives two new Italian patents
22nd Jun 20237:00 amRNSNew concept for produced water decontamination
15th Jun 20235:40 pmRNSResult of AGM
8th Jun 20237:00 amRNSNew product launch
19th May 20237:00 amRNSPosting of Annual Report and Notice of AGM
10th May 20237:00 amRNSFinal Results
9th May 20237:00 amRNSNew contract with customer Alfredo Grassi
27th Apr 20237:00 amRNSNotice of Results Presentations
20th Mar 20237:00 amRNSNew Patent Granted
27th Feb 20237:00 amRNSTrading Update and Notice of Results
21st Dec 20227:00 amRNSNew significant contract with Pigmentsolution
5th Dec 20222:05 pmRNSSecond Price Monitoring Extn
5th Dec 20222:00 pmRNSPrice Monitoring Extension
2nd Dec 20227:00 amRNSTrading Update
29th Nov 20227:00 amRNSGrant Award
21st Nov 20227:00 amRNSDirectorate Change
28th Oct 20227:00 amRNSFirst Commercial Contract in Latin America
21st Oct 20227:00 amRNSFirst Major Commercial Contract for Gipave
17th Oct 20227:00 amRNSBoar Changes
17th Oct 20227:00 amRNSBoard Changes
29th Sep 202211:05 amRNSSecond Price Monitoring Extn
29th Sep 202211:00 amRNSPrice Monitoring Extension
29th Sep 20227:00 amRNSHalf-year Report
1st Sep 20227:00 amRNSTrading Statement
30th Aug 20227:00 amRNSUS Patent Notice
4th Aug 20227:00 amRNSPartnership Extension and US Patent Award
19th Jul 20227:00 amRNSAgreement with REDA Energy for Grafysorber
5th Jul 20227:00 amRNSSupply Agreement
22nd Jun 20227:00 amRNSGrant of Italian Filtration Patent
17th Jun 20223:40 pmRNSResult of AGM
17th Jun 20227:00 amRNSAGM Statement
19th May 20227:00 amRNSPosting of Annual Report and Notice of AGM
5th May 20227:00 amRNSFinal Results
22nd Apr 20227:00 amRNSPartnership to Develop Automotive Fabrics
4th Apr 20227:00 amRNSUS EPA Authorises Grafysorber for Use in US
7th Mar 20227:00 amRNSOxfordshire Starts Second Trial of GiPave

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.